Enzo Biochem, Inc. (N:ENZ)

Business Focus: Medical & Diagnostic Laboratories

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for ENZ within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET January 25th, 2021
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jan 13/21 Jan 11/21 Tagliaferri Mary Direct Ownership Stock Option (to acquire Common Stock) A - Grant, award or other under Rule 16b-3(d) 77,101  
Jan 13/21 Jan 11/21 Weiner Barry W Direct Ownership Common Stock, par value $0.01 per share A - Grant, award or other under Rule 16b-3(d) 142,586  
Jan 13/21 Jan 11/21 Fischer Rebecca J. Direct Ownership Stock Option (to acquire Common Stock) A - Grant, award or other under Rule 16b-3(d) 77,101  
Jan 13/21 Jan 11/21 Rabbani Elazar Direct Ownership Common Stock, par value $0.01 per share A - Grant, award or other under Rule 16b-3(d) 190,114  
Jan 13/21 Jan 11/21 Perlysky Dov Direct Ownership Stock Option (to acquire Common Stock) A - Grant, award or other under Rule 16b-3(d) 77,101  
Jan 13/21 Jan 11/21 Bench David Direct Ownership Stock Option (to acquire Common Stock) A - Grant, award or other under Rule 16b-3(d) 55,400  
Jan 13/21 Jan 11/21 Walters Ian B. Direct Ownership Stock Option (to acquire Common Stock) A - Grant, award or other under Rule 16b-3(d) 77,101  
Apr 29/20 Apr 23/20 Blank Fabian Direct Ownership Stock Option (to acquire Common Stock) A - Grant, award or other under Rule 16b-3(d) 83,333  
Apr 29/20 Apr 23/20 Clemens Peter J Iv Direct Ownership Stock Option (to acquire Common Stock) A - Grant, award or other under Rule 16b-3(d) 83,333  
Apr 28/20 Apr 23/20 Clemens Peter J Iv Direct Ownership Stock Option (to acquire Common Stock) A - Grant, award or other under Rule 16b-3(d) 83,333  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for ENZ within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET January 25th, 2021
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jan 13/21 Jan 11/21 Tagliaferri Mary Direct Ownership Stock Option (to acquire Common Stock) A - Grant, award or other under Rule 16b-3(d) 77,101  
Jan 13/21 Jan 11/21 Weiner Barry W Direct Ownership Common Stock, par value $0.01 per share A - Grant, award or other under Rule 16b-3(d) 142,586  
Jan 13/21 Jan 11/21 Fischer Rebecca J. Direct Ownership Stock Option (to acquire Common Stock) A - Grant, award or other under Rule 16b-3(d) 77,101  
Jan 13/21 Jan 11/21 Rabbani Elazar Direct Ownership Common Stock, par value $0.01 per share A - Grant, award or other under Rule 16b-3(d) 190,114  
Jan 13/21 Jan 11/21 Perlysky Dov Direct Ownership Stock Option (to acquire Common Stock) A - Grant, award or other under Rule 16b-3(d) 77,101  
Jan 13/21 Jan 11/21 Bench David Direct Ownership Stock Option (to acquire Common Stock) A - Grant, award or other under Rule 16b-3(d) 55,400  
Jan 13/21 Jan 11/21 Walters Ian B. Direct Ownership Stock Option (to acquire Common Stock) A - Grant, award or other under Rule 16b-3(d) 77,101  
Apr 29/20 Apr 23/20 Blank Fabian Direct Ownership Stock Option (to acquire Common Stock) A - Grant, award or other under Rule 16b-3(d) 83,333  
Apr 29/20 Apr 23/20 Clemens Peter J Iv Direct Ownership Stock Option (to acquire Common Stock) A - Grant, award or other under Rule 16b-3(d) 83,333  
Apr 28/20 Apr 23/20 Clemens Peter J Iv Direct Ownership Stock Option (to acquire Common Stock) A - Grant, award or other under Rule 16b-3(d) 83,333  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $ENZ

  • No tweets found

Competitors

Competitors with Recent Insider Filings
NeoGenomics (OQ:NEO)
Biodesix (OQ:BDSX)
RadNet (OQ:RDNT)

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please subscribe. Our packages start at $1.00 plus tax for the first month.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.